|
is an NIH Distinguished Investigator and Chief of the Laboratory of Integrative Cancer Immunology, CCR, NCI in Bethesda, MD, USA.
He received his M.D. from the University of Torino, Italy in 1973.
|
 |
|
Before his position at NCI, he served in multiple capacities at the Basel Institute for Immunology, the Medical Genetics Institute at the Medical School of Torino, the Wistar Institute and Department of Medicine of the University of Pennsylvania, the Swiss Institute for Experimental Cancer Research in Epalinges, Switzerland, the Schering Plough Laboratory for Immunological Research in Dardilly, France, and the Laboratory for Parasitic Diseases, NIAID. He has been interested for many years in the interplay between inflammation/innate resistance and adaptive immunity, and in the role of pro-inflammatory cytokines and interferons in the regulation of haematopoiesis, innate resistance and immunity against infections and tumors. His laboratory’s main focus is the role of inflammation, innate resistance, immunity, and commensal microbiota in carcinogenesis, cancer progression, and prevention or therapy of cancer. |
|
